LY-2874455 10 mg | ≥98% LKT Laboratories, Inc. FGFR inhibitor. More Information Supplier Page × LY-2874455
LY-2874455 5 mg | ≥98% LKT Laboratories, Inc. FGFR inhibitor. More Information Supplier Page × LY-2874455
LY-2874455 1 mg | ≥98% LKT Laboratories, Inc. FGFR inhibitor. More Information Supplier Page × LY-2874455
TL-32711 10 mg | ≥98% LKT Laboratories, Inc. Smac mimetic; IAP inhibitor. More Information Supplier Page × TL-32711
TL-32711 5 mg | ≥98% LKT Laboratories, Inc. Smac mimetic; IAP inhibitor. More Information Supplier Page × TL-32711
GSK-343 5 mg | ≥98% LKT Laboratories, Inc. EZH2 HMT inhibitor. More Information Supplier Page × GSK-343
GSK-343 10 mg | ≥98% LKT Laboratories, Inc. EZH2 HMT inhibitor. More Information Supplier Page × GSK-343
AZD-2014 10 mg | ≥98% LKT Laboratories, Inc. mTOR inhibitor. More Information Supplier Page × AZD-2014
AZD-2014 5 mg | ≥98% LKT Laboratories, Inc. mTOR inhibitor. More Information Supplier Page × AZD-2014
AZD-2014 1 mg | ≥98% LKT Laboratories, Inc. mTOR inhibitor. More Information Supplier Page × AZD-2014
